STAMFORD, Conn. – March 25, 2021 – Avrio Health L.P., a subsidiary of Purdue Pharma L.P., today announced the launch of two Senokot® Dietary Supplement Products: Senokot Laxative* Gummies – Blueberry Pomegranate flavor, and Senokot Laxative* Tea.
Senokot Dietary Supplement Laxative* Gummies – Blueberry Pomegranate flavor is a new flavor of Senokot Laxative* Gummies for gentle overnight relief of occasional constipation. †* Made from a natural senna plant, Senokot Laxative* Gummies are for occasional constipation relief.* This product is available online now, and in retail stores in June.
Senokot Dietary Supplement Laxative* Tea is a blend of natural and organic senna and chamomile that offers a sweet flavor with subtle cinnamon and floral notes. Relax with a cup before bedtime to provide overnight relief of occasional constipation. †* This product is available online in April and in retail stores in June.
These two products exemplify the ways in which Avrio Health continues to strengthen its core brand, Senokot.
†When taken at bedtime
*This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
If pregnant, nursing or taking any medications, consult a healthcare professional before use. Do not take this product if you are allergic to any of the ingredients. Keep out of reach of children. In case of accidental overdose, seek professional assistance or contact a Poison Control Center immediately.
Do not exceed the recommended amount or use this supplement for longer than 1 week unless directed by a doctor. Read the full product label before using.
About Avrio Health L.P.
Avrio Health L.P., a subsidiary of Purdue Pharma L.P., is a consumer health products company that champions an improved quality of life for people in the United States through the reimagining of innovative product solutions. We have a strong portfolio of well-respected and proven effective brands, including Betadine®, Colace®, Senokot®, and SlowMag® Mg.
About Purdue Pharma L.P.
Purdue Pharma and its subsidiaries are physician-founded and physician-led companies that develop, manufacture and market medications and consumer health products to meet the evolving needs of healthcare professionals, patients, consumers and caregivers. Purdue Pharma is also committed to driving innovations in patient care while continuing our efforts to address the opioid crisis.
Purdue’s subsidiaries include: Adlon Therapeutics L.P., focused on treatment options for Attention-Deficit/Hyperactivity Disorder (ADHD) and related disorders; Avrio Health L.P., a consumer wellness company that provides over-the-counter products to fight infection, promote digestive wellness and provide health supplements; Imbrium Therapeutics L.P., established to develop and commercialize non-opioid pain medications and therapies for select oncology and CNS disorders; Rhodes Pharmaceuticals L.P., which develops and supplies primarily solid oral-dose and transdermal medications; and Greenfield Bioventures L.P., an investment vehicle focused on compounds in the early stages of clinical development.
For more information, visit www.purduepharma.com.